Handzlik-Orlik Gabriela, Krysiak Robert, Kędzierski Leszek, Okopień Boguslaw
Przegl Lek. 2016;73(5):324-33.
The liver is an organ implicated in a wide range of functions including protein, lipid and carbohydrate metabolism as well as hormone modification and degradation. Hence, liver disorders, comprising inflammatory processes and liver failure, may significantly influence endocrine homeostasis. Liver dysfunction leads to impaired protein synthesis, including hormone production disorders. Furthermore, endocrine disorders may be causally connected not only with primary liver disease, but they may also develop secondary to liver disease therapy. On the other hand, endocrine glands influence cell metabolism and distribution of body fat, and therefore, may contribute to development of liver diseases, such as non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). The increased incidence of these diseases is inseparably related to growing epidemic of obesity. The aim of this review is to discuss changes in endocrine homeostasis in the presence of liver dysfunction. According to vast literature regarding glucose homeostasis and adipokines in liver diseases, this problem will not be discussed in our review.
肝脏是一个涉及多种功能的器官,包括蛋白质、脂质和碳水化合物代谢以及激素修饰和降解。因此,包括炎症过程和肝衰竭在内的肝脏疾病可能会显著影响内分泌稳态。肝功能障碍会导致蛋白质合成受损,包括激素产生紊乱。此外,内分泌紊乱不仅可能与原发性肝病有因果关系,也可能继发于肝病治疗。另一方面,内分泌腺影响细胞代谢和身体脂肪分布,因此,可能促成肝病的发展,如非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)。这些疾病发病率的增加与肥胖症的日益流行密切相关。本综述的目的是讨论肝功能障碍时内分泌稳态的变化。根据关于肝病中葡萄糖稳态和脂肪因子的大量文献,本综述将不讨论这个问题。